NJ State Employees Deferred Compensation Plan - THERAVANCE INC ownership

THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 1 filers reported holding THERAVANCE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NJ State Employees Deferred Compensation Plan ownership history of THERAVANCE INC
ValueSharesWeighting
Q4 2015$1,075,000
+46.9%
102,0000.0%0.22%
+39.9%
Q3 2015$732,000
-19.0%
102,000
+104.0%
0.16%
-10.2%
Q2 2015$904,000
+15.0%
50,0000.0%0.18%
+15.8%
Q1 2015$786,000
+11.0%
50,0000.0%0.15%
+10.1%
Q4 2014$708,000
-17.1%
50,0000.0%0.14%
-20.7%
Q3 2014$854,000
-42.7%
50,0000.0%0.17%
-41.0%
Q2 2014$1,490,000
-3.7%
50,0000.0%0.30%
-7.2%
Q1 2014$1,548,00050,0000.32%
Other shareholders
THERAVANCE INC shareholders Q3 2023
NameSharesValueWeighting ↓
Baupost Group 19,815,983$338,655,0005.90%
Litespeed Management, L.L.C. 2,670,695$45,642,0001.76%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 2,790,913$47,697,0001.76%
Proxima Capital Management, LLC 915,000$15,637,0001.69%
IRIDIAN ASSET MANAGEMENT LLC/CT 8,196,372$140,076,0001.44%
PERRY CAPITAL 1,831,099$31,293,0001.14%
Roundview Capital LLC 140,145$2,395,0001.08%
SECTORAL ASSET MANAGEMENT INC 971,438$16,602,0000.70%
Realm Partners LLC 139,982$2,392,0000.68%
BB BIOTECH AG 743,244$12,702,0000.52%
View complete list of THERAVANCE INC shareholders